Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 56,214 followers.

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology: Blood products in therapeutic transfusion are now commonly acknowledged to contain biologically active… #immunology https://t.co/JQAGz8gyJZ

11 Oct 2022

Reply Repost Favourite

New Research: Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology: Blood products in therapeutic transfusion are now commonly acknowledged to contain biologically active… https://t.co/F3M42VHUO

08 Oct 2022

Reply Repost Favourite

Very interesting paper on impact pathogen inactivation & cytokines in #convalescent plasma #immune #covid19 ⬇️

28 Sep 2022

Reply Repost Favourite

RT @FCognasse: Our latest publication in Frontiers Immunology, Inflammatory Profile of Convalescent Plasma to Treat COVID: Impact of Amoto…

28 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.